Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 8,175Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 24BRISTOL MYERS SQUIBB

02 42NANOCOPOEIA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

DASATINIB

US Patent Number : 7491725

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

blank

02

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

DASATINIB

US Patent Number : 7491725

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

blank

03

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

DASATINIB

US Patent Number : 8680103

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-02-04

blank

04

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

DASATINIB

US Patent Number : 7491725

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

blank

05

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

DASATINIB

US Patent Number : 7491725

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

blank

06

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

DASATINIB

US Patent Number : 8680103

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-02-04

blank

07

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

DASATINIB

US Patent Number : 8680103

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-02-04

blank

08

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

DASATINIB

US Patent Number : 8680103

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-02-04

blank

09

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

DASATINIB

US Patent Number : 8680103

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-02-04

blank

10

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

DASATINIB

US Patent Number : 8680103

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21986

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-02-04

blank